Skip to search formSkip to main contentSkip to account menu

Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Reduced Analgesics Consumption and Pain Intensity after Injections with a New Hyaluronic Acid in Patients with Knee Osteoarthritis
Abstract Objective: To determine the influence of a new intraarticular hyaluronic acid based hydrogel (Hymovis®) injections on… 
2017
2017
Changes in Knee Joint Space Width in Treatment with a New Hyaluronic-Based Hydrogel
Abstract Objective: Our purpose was to assess the effect of a new hyaluronic acid-based (Hymovis®) injections on joint space… 
2013
2013
AB0083 Anti-inflammatory effect of hymovis® on an in vitro model of CPP crystal-induced inflammation. Comparison with other hyaluronic acids used for intra-articular treatment
Background Intra-articular injections of hyaluronic acid (HA) are widely used in the treatment of inflammatory and degenerative… 
2013
2013
A hexadecylamide derivative of hyaluronan (HYMOVIS®) has superior beneficial effects on human osteoarthritic chondrocytes and synoviocytes than unmodified hyaluronan
Intra-articular hyaluronan (HA) injection provides symptomatic benefit in the treatment of osteoarthritis (OA). Previously we… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)